市場調査レポート

商品コード

自己免疫疾患診断の市場規模、シェア、成長分析、製品別、検査タイプ別、疾患タイプ別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Autoimmune Disease Diagnostics Market Size, Share, Growth Analysis, By Product, By Test Type, By Disease Type, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年10月06日 | 発行: SkyQuest

| ページ情報: 英文 157 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 800,088円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 935,952円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,071,816円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.96円

全表示
概要
目次

概要

サンプル依頼リストに入れる

自己免疫疾患診断の世界市場規模は、2022年に43億8,000万米ドルと評価され、2023年の45億6,000万米ドルから2031年には63億2,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは4.15%で成長する見通しです。

自己免疫疾患の診断市場は、自己免疫疾患の世界的な蔓延に牽引されて大幅な拡大を遂げています。自己免疫疾患はさまざまな臓器やシステムに影響を及ぼし、効果的な管理にはタイムリーで正確な診断が必要です。この発症率の増加は、遺伝的素因、環境の影響、ライフスタイルパターンの変化などの要因によって促進されており、これらの疾患を特定して監視するための診断テストの需要が高まっています。同時に、医療技術の進歩により診断手法の精度と効率が大幅に向上し、特定の自己免疫疾患の同定を容易にする多様な臨床検査、画像診断技術、特殊なアッセイが登場しています。これらの技術革新により、ヘルスケア専門家は患者のケアに関してより多くの情報に基づいた決定を下すことができるようになった。さらに、自己免疫疾患に対する患者やヘルスケア提供者の意識の高まりにより、患者の転帰を改善し合併症を予防するために重要な早期発見への取り組みが強化されています。その結果、世界の自己免疫疾患診断市場は力強い成長を遂げると予想され、中でも米国市場は今後予測される期間において力強いCAGRを維持すると予想されています。この動向は、自己免疫疾患の早期発見と効果的な管理がヘルスケアにおいて重要であることを補強し、診断ツールのさらなる技術革新と開発の大きな機会を意味しています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Abbott Laboratories
Thermo Fisher Scientific Inc.
Siemens AG
F. Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc.
Quest Diagnostics Incorporated
Hologic, Inc.
Danaher Corporation
Inova Diagnostics, Inc.
PerkinElmer Germany Diagnostics GmbH
Grifols, S.A.
Bio-Techne Corporation
Menarini Group
Myriad Genetics, Inc.
Medac GmbH
ImmunArray
Exagen Inc.
ORGENTEC Diagnostika GmbH
Seramun Diagnostica GmbH
SQI Diagnostics Inc.

Product Code: SQMIG35D2178

Global Autoimmune Disease Diagnostics Market size was valued at USD 4.38 billion in 2022 and is poised to grow from USD 4.56 billion in 2023 to USD 6.32 billion by 2031, growing at a CAGR of 4.15% during the forecast period (2024-2031).

The autoimmune disease diagnostics market is witnessing significant expansion driven by the escalating prevalence of autoimmune conditions globally, which are known to impact various organs and systems, necessitating timely and precise diagnosis for effective management. This increase in incidence is fueled by factors such as genetic predisposition, environmental influences, and shifting lifestyle patterns, boosting the demand for diagnostic tests tailored to identify and monitor these diseases. Concurrently, advancements in medical technology have greatly enhanced the accuracy and efficiency of diagnostic methodologies, with a diverse range of laboratory tests, imaging techniques, and specialized assays emerging to facilitate the identification of specific autoimmune disorders. These innovations empower healthcare professionals to make more informed decisions regarding patient care. Additionally, rising awareness among both patients and healthcare providers about autoimmune diseases has intensified the push for early detection, which is critical for improving patient outcomes and preventing complications. As a result, the global autoimmune disease diagnostics market is anticipated to experience robust growth, with the US market expected to sustain a strong compound annual growth rate (CAGR) in the coming forecast period. This trend signifies vast opportunities for further innovation and development of diagnostic tools, reinforcing the importance of early detection and effective management of autoimmune diseases in healthcare initiatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Autoimmune Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Autoimmune Disease Diagnostics Market Segmental Analysis

Global Autoimmune Disease Diagnostics Market is segmented by Product, Test Type, Disease Type, End User, and Region. Based on Product, the market is segmented into Reagents and consumables, Instruments. Based on Test Type, the market is segmented into Antinuclear antibody tests, Urinalysis, C-reactive protein (CRP), Complete blood count (CBC), Autoantibody tests, Other tests. Based on Disease Type, the market is segmented into Systemic autoimmune disease (Rheumatoid arthritis, Systemic lupus erythematosus (SLE), Psoriasis, Multiple sclerosis, Other systemic autoimmune diseases), Localized autoimmune disease (Inflammatory bowel disease, Type 1 diabetes, Thyroid, Other localized autoimmune diseases). Based on End User, the market is segmented into Hospitals, Diagnostics centers, Other end-users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Autoimmune Disease Diagnostics Market

Increased awareness among patients and healthcare professionals regarding autoimmune diseases has emerged as a significant market driver for the Global Autoimmune Disease Diagnostics market. As individuals become more knowledgeable about the symptoms and complexities of these diseases, there is a marked shift towards early recognition and timely diagnosis. This proactive approach facilitates the prompt initiation of treatment and effective management strategies, ultimately enhancing patient outcomes. Consequently, the heightened awareness fuels a growing demand for advanced diagnostic tests that support early detection and ongoing monitoring of autoimmune conditions, thereby driving innovations and investments within the diagnostics sector.

Restraints in the Global Autoimmune Disease Diagnostics Market

The high cost of autoimmune disease diagnostic tests serves as a significant market restraint for the global Autoimmune Disease Diagnostics market. Advanced and specialized testing often comes with substantial expenses that can restrict access for patients, particularly in underdeveloped or underinsured regions where healthcare resources are limited. This financial barrier not only deters patients from seeking timely diagnosis but also impedes the widespread adoption of innovative diagnostic solutions. Furthermore, inadequate insurance coverage compounds this issue, leading to delays in diagnosis and treatment, ultimately reducing the overall demand for such diagnostic tools and limiting their market growth potential.

Market Trends of the Global Autoimmune Disease Diagnostics Market

The Global Autoimmune Disease Diagnostics market is experiencing significant growth, driven by rapid technological advancements in medical diagnostics. Innovations such as high-throughput screening, next-generation sequencing, and advanced imaging techniques are enhancing the accuracy and efficiency of autoimmune disease detection and monitoring. These state-of-the-art diagnostic tools enable healthcare providers to identify specific autoimmune disorders more reliably and swiftly, thereby improving patient outcomes. The rising prevalence of autoimmune diseases and increasing healthcare expenditure further fuel market demand, prompting investment in research and development of specialized assays and laboratory tests tailored for autoimmune conditions. Overall, the market is poised for robust expansion.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Ecosystem of the Market
Value Chain Analysis
PESTEL Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Autoimmune Disease Diagnostics Market by Product

Market Overview
Instruments
Reagents and consumables

Autoimmune Disease Diagnostics Market by Test Type

Market Overview
Antinuclear antibody tests
Urinalysis
C-reactive protein (CRP)
Complete blood count (CBC)
Autoantibody tests
Other tests

Autoimmune Disease Diagnostics Market by Disease Type

Market Overview
Systemic autoimmune disease
- Rheumatoid arthritis
- Systemic lupus erythematosus (SLE)
- Psoriasis
- Multiple sclerosis
- Other systemic autoimmune diseases
Localized autoimmune disease
- Inflammatory bowel disease
- Type 1 diabetes
- Thyroid
- Other localized autoimmune diseases

Autoimmune Disease Diagnostics Market by End User

Market Overview
Hospitals
Diagnostics centers
Other end-users

Autoimmune Disease Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inova Diagnostics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Germany Diagnostics GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Menarini Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medac GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ImmunArray
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exagen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ORGENTEC Diagnostika GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seramun Diagnostica GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SQI Diagnostics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

自己免疫疾患診断の市場規模、シェア、成長分析、製品別、検査タイプ別、疾患タイプ別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Autoimmune Disease Diagnostics Market Size, Share, Growth Analysis, By Product, By Test Type, By Disease Type, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

自己免疫疾患診断市場：製品別

自己免疫疾患診断市場：検査タイプ別

自己免疫疾患診断市場：疾患タイプ別

自己免疫疾患診断市場：エンドユーザー別

自己免疫疾患診断市場規模：地域別